目的:研究同时多导管冷冻疗法在治疗先前对标准射频(RF)导管消融有抵抗力的AP中的应用。
背景:导管消融是在辅助途径(AP)的治疗中建立的,一次尝试就能获得很高的永久程序成功率。然而,使用标准射频和冷冻治疗方法,仍有急性手术失败和AP复发的情况.
方法:连续7例先于射频导管消融失败的预激综合征患者采用了新的治疗方法。使用两根8mm头端局灶性冷冻消融导管(Freezor®Max,美敦力,明尼阿波利斯,明尼苏达,美国)。
结果:附件通路定位为间隔5例,左后外侧在1,右外侧在1。在所有情况下,AP消融非常成功,无手术并发症.中位手术和透视持续时间分别为199和35分钟,顺序。与前半部分(233分钟,P=0.05)。在5周的随访中,一名患者有反复发作的AP传导和预激的证据。在中位随访66.8+-6.5个月后,7例患者中有6例无症状且无预激。
结论:同时进行多导管冷冻治疗是可行的,安全,可以对以前对标准射频消融有抵抗力的辅助途径提供明确的治疗。在评估这种新型的先进冷冻疗法以治疗复杂和顽固性心律失常时,需要进一步的研究。
OBJECTIVE: To investigate the utility of simultaneous multi-catheter cryotherapy for the treatment of APs that were previously resistant to standard radiofrequency (RF) catheter ablation.
BACKGROUND: Catheter ablation is established in the treatment of accessory pathways (AP), with high rates of permanent procedural success with a single attempt. However, there are still instances of acute procedural failure and AP recurrences with standard RF and cryotherapy methods.
METHODS: Seven consecutive cases of pre-excitation syndromes with prior failed RF catheter ablation had the novel treatment. Cryotherapy was delivered using two 8 mm tip focal cryoablation catheters (Freezor® Max, Medtronic, Minneapolis, Minnesota, USA).
RESULTS: Accessory pathway localisation was septal in 5 cases, left posterolateral in 1, right lateral in 1. In all cases, ablation of the AP was acutely successful with no procedural complications. Median procedure and fluoroscopy durations were 199 and 35 min, sequentially. Median Procedure duration fell significantly in the second half of series (174 min) compared to the first half (233 min, P = 0.05). One patient had evidence of a recurring AP conduction with pre-excitation at 5-week follow up. After a median follow up of 66.8+-6.5 months, 6 out of 7 patients remained asymptomatic and free of pre-excitation.
CONCLUSIONS: Simultaneous multi-catheter cryotherapy is feasible, safe and can provide definitive cure of accessory pathways that were previously resistant to standard radiofrequency ablation. Further study is required in the assessment of this novel form of advanced cryotherapy to treat complex and resistant arrhythmias.